ASC Biosciences, Inc. acquired Nevis Capital Corporation (OTCPK:OCEE) in a reverse merger transaction on May 15, 2017. The transaction was a court ordered acquisition. Under the terms, ASC Biosciences issued 8.02 million post-split shares to Nevis Capital and announced a 1-for-2000 reverse stock split of its existing shares. Following its acquisition by ASC Biosciences, Inc., Nevis Capital Corporation has now been renamed as ASC Biosciences and guided by ASC Biosciences's management team, will assume ASC Biosciences's current business plan. By order of the court, new Directors and Officers have been appointed to ASC Biosciences, Inc. For the next twenty days, Nevis Capital has been authorized by FINRA to trade with the symbol OCEED, which at the expiry of said twenty days will change to ASCW. ASC Biosciences, Inc. completed the acquisition of Nevis Capital Corporation (OTCPK:OCEE) in a reverse merger transaction on May 15, 2017.